NasdaqGM:NVTS
NasdaqGM:NVTSSemiconductor

Navitas Semiconductor (NVTS): Revisiting Valuation After a Sharp Weekly Pullback and Strong One-Year Gains

Navitas Semiconductor (NVTS) has quietly delivered huge gains over the past year, even as the stock slipped almost 20% in the past week, inviting a closer look at what might come next. See our latest analysis for Navitas Semiconductor. That recent 7 day share price drop of 19.72% looks more like a sharp pause than a trend change, given Navitas still boasts a year to date share price return of 111.17% and a 1 year total shareholder return of 162.28%. This suggests momentum has cooled but not...
NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

A Fresh Look at ArcBest (ARCB) Valuation After Stifel Lifts Its Price Target and Reaffirms Buy Rating

Stifel’s refreshed call on ArcBest (ARCB), keeping a Buy rating while lifting its outlook, has put the trucking and logistics name back on investors’ radar as sentiment across Wall Street turns more constructive. See our latest analysis for ArcBest. The upgraded call comes as momentum has quietly turned in ArcBest’s favor, with the share price at 80.47 dollars and a strong 1 month share price return of just over 32 percent helping to claw back some of this year’s earlier weakness. However,...
NYSE:WM
NYSE:WMCommercial Services

Has the Market Already Priced In Waste Management’s Recycling Push and Steady 2025 Gains?

For investors wondering whether Waste Management is still attractively priced at around $218 a share or whether much of the opportunity has already been realized, this article will walk through what the numbers indicate about its valuation. The stock has gained 1.3% over the last week and 1.2% over the last month, and is up 8.9% year to date, adding to a track record of 7.6% over 1 year, 43.7% over 3 years, and 101.9% over 5 years. Recent headlines have highlighted Waste Management's...
NYSE:FHI
NYSE:FHICapital Markets

Is It Too Late To Consider Federated Hermes After Its Strong 32.8% Share Price Climb?

If you are wondering whether Federated Hermes remains attractively valued after its recent run up, or if that value is already fully reflected in the price, this piece will walk you through what the current share price is really implying. The stock has quietly delivered a 10.2% gain over the last month and is up 32.8% over the past year, with a strong 125.1% climb over five years that is making long term holders very happy. Recently, the company has stayed in the spotlight as investors...
NYSE:PCG
NYSE:PCGElectric Utilities

How Investors May Respond To PG&E (PCG) Overhaul Of Leadership And Energy Delivery Structure

Earlier this week, PG&E Corporation CEO Patti Poppe announced a major leadership reorganization effective January 1, 2026, reshaping operations, customer and corporate affairs, strategy, transformation, and government engagement across its Northern and Central California footprint. The creation of focused roles like an Energy Delivery CEO and a Chief Transformation Officer highlights PG&E’s push to integrate operations, customer service and process modernization under clearer...
LSE:RR.
LSE:RR.Aerospace & Defense

Rolls-Royce (LSE:RR.) Valuation Check After Strong Recent Share Price Gains

Rolls-Royce Holdings (LSE:RR.) has quietly extended its strong run, with the share price gaining about 2% over the past day, 7% this week, and nearly 10% over the past month. See our latest analysis for Rolls-Royce Holdings. Those gains come on top of a powerful backdrop, with the share price delivering a roughly doubling year to date and a three year total shareholder return above 1,100%, signalling that momentum is very much still building as investors reassess Rolls Royce Holdings growth...
NYSE:MSCI
NYSE:MSCICapital Markets

Is MSCI Fairly Priced After Recent ESG and Passive Investing Tailwinds in 2025?

If you have ever looked at MSCI and wondered whether the current share price really makes sense, you are not alone. This article is going to unpack that valuation puzzle step by step. MSCI is trading around $562.40, up 2.1% over the last week and 0.5% over the last month, even though the stock is still down 5.8% year to date and over the past year, while longer-term 3-year and 5-year returns of 25.6% and 36.9% hint at a business that has compounded value over time. Recently, investors have...
NYSE:ESTC
NYSE:ESTCSoftware

Elastic (ESTC) Valuation Check After Winning Major CISA SIEMaaS Cybersecurity Contract

Elastic (NYSE:ESTC) is back in focus after securing a multiyear agreement with the U.S. Cybersecurity and Infrastructure Security Agency to build a standardized SIEM as a Service platform for federal civilian agencies. See our latest analysis for Elastic. The CISA deal comes at a time when Elastic’s share price has pulled back, with a year-to-date share price return of negative 23.14 percent and a one-year total shareholder return of negative 26.55 percent. However, a three-year total...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Ascendis Pharma (ASND): Revisiting Valuation After Recent Pullback and Strong 1-Year Shareholder Returns

Ascendis Pharma (ASND) has quietly given back some ground over the past week, even though its longer term performance remains strong. With shares near 200 dollars, investors are weighing solid growth against ongoing losses. See our latest analysis for Ascendis Pharma. Despite the recent 7 day share price return of negative 9.4 percent, Ascendis still boasts a robust year to date share price return of about 45 percent and a 1 year total shareholder return of roughly 47 percent. This suggests...
NYSE:TGT
NYSE:TGTConsumer Retailing

Target (TGT) Valuation Check After FDA Warning on Recalled Infant Formula and Compliance Concerns

Target (TGT) just landed in the regulatory spotlight after the FDA issued a public warning, saying recalled ByHeart infant formula linked to a multistate botulism outbreak was still being sold and even promoted in its stores. See our latest analysis for Target. The FDA warning lands at a tricky moment for Target, with the share price at $99.05 after a strong 1 month share price return of 15.07 percent. However, the 1 year total shareholder return is a much weaker negative 21.34 percent,...
TSX:BNS
TSX:BNSBanks

Is Bank of Nova Scotia (TSX:BNS) Still Undervalued After Its Recent Share Price Rally?

Recent Performance and Why Bank of Nova Scotia Matters Now Bank of Nova Scotia (TSX:BNS) has quietly put together a strong run, with shares up about 29% this year and roughly 36% over the past year, outpacing many Canadian bank peers. See our latest analysis for Bank of Nova Scotia. That rally looks more like a re-rating than a blip, with a roughly 28.6% year to date share price return and a powerful 92.36% five year total shareholder return. This signals that momentum is building as...
NYSE:MPC
NYSE:MPCOil and Gas

Will Marathon Petroleum’s (MPC) New CFO Recalibrate the Balance Between Growth Investment and Shareholder Returns?

Marathon Petroleum has appointed Maria A. Khoury as Executive Vice President and Chief Financial Officer, effective January 19, 2026, succeeding John J. Quaid after a transition period. Khoury’s blend of oil and gas, life sciences, and global finance experience positions her to influence Marathon’s capital allocation and risk management approach in meaningful ways. We’ll now examine how bringing in a globally experienced CFO from Danaher could influence Marathon Petroleum’s investment...
NYSE:ACI
NYSE:ACIConsumer Retailing

Should FDA Recall Failures in Infant Formula Oversight Require Action From Albertsons Companies (ACI) Investors?

In November 2025, the FDA issued a warning letter to Albertsons after regulators found recalled ByHeart Whole Nutrition Infant Formula linked to a multistate infant botulism outbreak still available for purchase across multiple Albertsons-affiliated stores in 11 states. The letter highlights serious gaps in Albertsons’ recall execution and communication processes, raising questions about its food safety controls and regulatory risk management. We’ll now examine how this FDA warning, centered...
NasdaqGS:HOLX
NasdaqGS:HOLXMedical Equipment

Does Hologic’s Expanding Diagnostics Portfolio Make the Current Share Price Look Attractive?

Investors may be wondering whether Hologic at around $74.94 is quietly turning into good value, or if it is just treading water while other healthcare names run ahead of it. Over the last year the stock is up about 4.6%, with a modest 4.5% gain year to date, while short-term moves have been fairly muted, down 0.1% over the last week and up 1.0% over the last month. Recent headlines have focused on Hologic expanding its portfolio of diagnostic and women’s health technologies and deepening...
NYSE:PCOR
NYSE:PCORSoftware

Assessing Procore Technologies (PCOR) Valuation After Board and CEO Transitions Refocus Investor Attention

Procore Technologies (PCOR) has been back in focus after a fresh board reshuffle and an incoming CEO, with investors parsing what this evolving leadership team could mean for its construction focused AI strategy and stock trajectory. See our latest analysis for Procore Technologies. Those leadership changes and the company’s recent conference appearances seem to be feeding into a slow but constructive shift in sentiment, with a modest single digit 3 month share price return and a much...
TSE:2502
TSE:2502Beverage

Assessing Asahi Group Holdings (TSE:2502)’s Valuation After Recent Share Price Weakness

Asahi Group Holdings (TSE:2502) has been drifting lower over the past month, even as its long term track record and steady earnings growth keep the stock on many income and quality watchlists. See our latest analysis for Asahi Group Holdings. That recent 7 day share price return of negative 6.95 percent sits against a mildly positive year to date share price gain and a solid three year total shareholder return of 27.94 percent, suggesting near term momentum is cooling while the longer term...
NYSE:GNL
NYSE:GNLREITs

Revisiting Global Net Lease (GNL) Valuation After Its Recent Total Return Rebound

Why Global Net Lease is Back on Income Investors Radar Global Net Lease (GNL) has quietly delivered a 33% 1 year total return, and that kind of move in a higher yield REIT immediately raises the question: is this momentum sustainable or already priced in? See our latest analysis for Global Net Lease. That recent 7.5% 1 month share price return, on top of a 15.2% year to date share price gain, suggests momentum is rebuilding even though the longer term total shareholder return is still...
NYSE:ACN
NYSE:ACNIT

Accenture (ACN) Q1 2026 Margin Slippage Reinforces Concerns Over Slowing Profit Growth

Accenture (ACN) opened fiscal 2026 with Q1 revenue of about $18.7 billion and basic EPS of $3.57, setting the tone for another year where profit growth is firmly in focus. The company has seen quarterly revenue move from roughly $16.4 billion in Q4 2024 to $18.7 billion in Q1 2026, while basic EPS has ranged between about $2.27 and $3.64 over that stretch. This gives investors a clear view of how top line and per share earnings have been tracking. With trailing net margins easing a touch and...
TASE:NICE
TASE:NICESoftware

What NICE (TASE:NICE)'s South Africa CXone Mpower Local Cloud Launch Means For Shareholders

In December 2025, NICE launched its AI-powered CXone Mpower platform on locally hosted cloud infrastructure in South Africa, supported by redundant data centers in Cape Town and Johannesburg to serve regulated sectors and large enterprises. By keeping both applications and voice traffic within South Africa, NICE is directly addressing data governance, latency, and call quality requirements that are critical for banks and other highly regulated industries across the region. We’ll now...
CNSX:CL
CNSX:CLPharmaceuticals

Cresco Labs (CNSX:CL) Is Up 55.2% After Cannabis Rescheduling News Is The Bull Case Changed?

Cresco Labs recently welcomed the U.S. federal government’s move to reschedule cannabis from Schedule I to Schedule III, calling it a historic policy shift for the regulated cannabis industry. The company highlighted that rescheduling could ease tax burdens, improve access to banking and research, and further legitimize state-regulated cannabis markets, directly supporting its brand-building and expansion efforts. We’ll now examine how easing federal tax burdens and banking frictions could...
NasdaqCM:ABTC
NasdaqCM:ABTCSoftware

American Bitcoin (ABTC): Assessing Valuation After a Sharp Multi-Month Share Price Pullback

American Bitcoin stock reacts to mounting losses and sharp pullback American Bitcoin (ABTC) has quietly slid over the past month, with the stock down roughly 66% and about 78% in the past 3 months. This has prompted investors to reassess its Bitcoin focused model. See our latest analysis for American Bitcoin. That rapid drawdown sits on top of an already weak year to date share price return of about 75% and signals fading momentum as investors reassess both Bitcoin volatility and American...
NYSE:TT
NYSE:TTBuilding

Does Trane’s Data Center and AI HVAC Push Reshape the Bull Case For Trane Technologies (TT)?

In recent months, Trane Technologies has rolled out new circularity impact metrics tied to its 2030 Sustainability Commitments, announced acquisitions in data center-focused digital cooling and AI HVAC optimization, and reported higher adjusted EPS alongside record enterprise bookings and backlog. These moves, combined with renewed STEM education funding and workplace culture recognition, highlight how Trane is using sustainability, talent, and data center exposure to reinforce its...
TSE:9984
TSE:9984Wireless Telecom

Is It Too Late To Consider SoftBank After Its 2025 Rally And Mixed Valuation Signals?

If you are wondering whether SoftBank Group's huge run means you have already missed the opportunity, or if the stock still has room to surprise on the upside, you are in the right place. Despite a recent pullback, with the share price down 4.4% over the last week and 9.1% over the last month, SoftBank is still up 85.3% year to date and 96.1% over the past year. These moves sit against a backdrop of SoftBank reshaping itself into a more focused investment powerhouse, from headline grabbing...
NYSE:PSX
NYSE:PSXOil and Gas

Phillips 66 (PSX): Assessing Valuation After Recent Share Price Weakness

Market context and recent performance Phillips 66 (PSX) has been drifting lower in recent weeks, with the stock down around 9% over the past week and roughly 4% over the past month, even as its one year return remains solidly positive. See our latest analysis for Phillips 66. With the share price now at $129.13 and recent weakness reflected in its 7 day and 30 day share price returns, the longer term picture still looks constructive. This is supported by a 1 year total shareholder return...